Thermo Fisher Scientific (NYSE: TMO) director reports new phantom stock units
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Thermo Fisher Scientific director reports deferred stock unit grant
A Thermo Fisher Scientific Inc. (TMO) director reported receiving 64.72 phantom stock units on December 31, 2025 under the company’s Deferred Compensation Plan for Directors. These units are convertible into common stock on a 1-for-1 basis and were credited at a price of $579.45 per unit, based on the closing stock price at quarter end. Following this transaction, the director beneficially owns 2,638.67 derivative securities, held directly. Under the plan, directors’ retainers are deferred quarterly into common stock units, which are distributable as stock when director service ends for any reason or upon a change of control.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
WEISLER DION J
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Phantom Stock Units | 64.72 | $0.00 | -- |
Holdings After Transaction:
Phantom Stock Units — 2,638.67 shares (Direct)
Footnotes (1)
- Convertible into Common Stock on a 1-for-1 basis. Represents stock units credited to the Reporting Person's account as of December 31, 2025, at a price of $579.45 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the "Plan"). Directors' retainers are deferred quarterly under the Plan as Common Stock units based on the closing price of the stock as of the quarter end. The shares are distributable as stock upon cessation of director service (for any reason) or a change of control.